EcoDrugPlus

Inosine-5'-Monophosphate Dehydrogenase 1a

Ensembl ID : ENSPNYG00000013952
Gene Symbol: LOC102212509
4 Cross references
258 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSPNYG00000001120
Gene Symbol: LOC102194436
4 Cross references
257 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPNYG00000019357
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSPNYG00000007318
Gene Symbol: INSRB
1 Cross references
212 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSPNYG00000008035
Gene Symbol: LOC102205789
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSPNYG00000009876
Gene Symbol: LOC102215238
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSPNYG00000009411
Gene Symbol: LOC102213064
3 Cross references
203 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSPNYG00000003577
Gene Symbol: LOC102215413
3 Cross references
206 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSPNYG00000013913
Gene Symbol: LOC102210055
3 Cross references
228 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSPNYG00000011845
Gene Symbol: LOC102195566
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPNYG00000010626
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPNYG00000005301
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).